BTG3 and systemic sclerosis: Consistent with the literature, SSc patients with GAVE in our study were older at SSc disease onset (49.2 (40.0–58.2) vs 46.7 (35.9–56.7) years, p = 0.05); more likely to have dcSSc (35.3% vs 24.1%, p < 0.001) [14]; more likely to be ANA and RNAP III antibody positive [15] and negative for Scl-70 [15, 18].